368 The Use of Indocyanine Green (ICG) in Endoscopic Pituitary Surgery: A Systematic Review
British Journal of Surgery · 10.07.2026 · 113 (Supplement_6)
DOI: 10.1093/bjs/znag063.115 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift British Journal of Surgery, online erschienen am 10.07.2026. Verfasst von Y Jubouri und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Aim
Indocyanine Green (ICG) fluorescence imaging is increasingly utilised in endoscopic pituitary surgery to enhance intraoperative visualisation and precision. This systematic review evaluates its efficacy and clinical utility in improving tumour delineation, extent of resection, and anatomical orientation during surgery.
Method
A PRISMA-guided search of multiple electronic databases was conducted through February 2025. Eligible studies included adult patients undergoing endoscopic pituitary surgery with intraoperative ICG and reported surgical or diagnostic outcomes. Eleven studies (150 patients) met the inclusion criteria. Data on patient demographics, tumour characteristics, ICG administration protocols, fluorescence metrics, surgical and endocrine outcomes were extracted and analysed using weighted and proportional methods.
Results
ICG fluorescence successfully visualised targets in 93.6% of cases (n=87/93, range 75-100%), with onset 20 seconds to 32.5 minutes post-injection. Non-functioning adenomas were most common (55%, n=68/124), predominantly macroadenomas. ICG improved margin delineation, enabled mapping of the internal carotid artery and cavernous sinus, and aided real-time differentiation of adenoma from normal gland. Where studies reported diagnostic performance, Delayed-Window ICG (DWIG) demonstrated sensitivity 89% and specificity 75%, while Second-Window ICG (SWIG) achieved sensitivity 100% with specificity 20-29%. Complications were low; transient diabetes insipidus was most frequent (n=6). Gross total resection was achieved in most cases (n=53/65, range 80-87.5%), and no ICG-specific adverse events occurred.
Conclusions
ICG fluorescence is a promising adjunct in endoscopic pituitary surgery, improving intraoperative visualisation and anatomical guidance. Distinct from prior narrative reviews, this technique-stratified synthesis (bolus, DWIG, SWIG) integrates clinical outcomes. Standardised protocols and high-quality prospective studies are needed to validate diagnostic performance and define routine use.
Zitieren
APA
Jubouri, Y., Chikhal, R., Ahmed, S., & Jolly, K. (2026). 368 The Use of Indocyanine Green (ICG) in Endoscopic Pituitary Surgery: A Systematic Review. British Journal of Surgery, 113(Supplement_6). https://doi.org/10.1093/bjs/znag063.115
Vancouver
Jubouri Y, Chikhal R, Ahmed S, Jolly K. 368 The Use of Indocyanine Green (ICG) in Endoscopic Pituitary Surgery: A Systematic Review. British Journal of Surgery. 2026;113(Supplement_6). doi:10.1093/bjs/znag063.115
BibTeX
@article{Jubouri2026,
author = {Jubouri, Y and Chikhal, R and Ahmed, S and Jolly, K},
title = {368 The Use of Indocyanine Green (ICG) in Endoscopic Pituitary Surgery: A Systematic Review},
journal = {British Journal of Surgery},
year = {2026},
volume = {113},
number = {Supplement_6},
doi = {10.1093/bjs/znag063.115}
}
EUVIMED